KAREN SCHALLER: Open Payments
NPI 1518208172 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,579 in 92 payments from 19 companies in 2025. Trend: 2023 $2,621 · 2024 $2,405 · 2025 $2,579
Food & beverage: $2,418Education: $161
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 28 | $695 |
| Regeneron Healthcare Solutions, Inc. | 9 | $283 |
| GlaxoSmithKline, LLC. | 8 | $265 |
| Ionis Pharmaceuticals, Inc. | 5 | $244 |
| CSL Behring | 7 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $196 |
| BioCryst US Sales Co., LLC | 5 | $124 |
| GENZYME CORPORATION | 4 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| Verona Pharma, Inc. | 2 | $56 |
Products named: DUPIXENT, FASENRA, NUCALA, DAWNZERA, AIRSUPRA, TEZSPIRE, Haegarda, ORLADEYO.
Industry payments across PA — which companies pay providers there.
